Anthony Nolan / University College London
Based in Hampstead Heath, North London
£35,000 pa + benefits
3 year contract
Anthony Nolan was the first unrelated donor registry in the world, and to this day remains at the forefront of this field, both in research and in the quality of service it provides to transplant centres worldwide, whilst striving to maintain the highest standards in donor advocacy and safety.
Anthony Nolan would like to invite applications for an exciting new postdoctoral research scientist post in the immunotherapy group in the frame of the FP7 consortium “T-Control”. The immunotherapy group combines expertise in stem cell biology and cellular immunology, and works in close relationship with the cord blood program. The project aims to characterise cord blood regulatory T cells by comparing their therapeutic abilities with their adult counterparts in order to understand their unique properties and improve the outcome of haematopoietic stem transplantation by targeting graft versus host disease.
The applicant will have a PhD in immunology and have demonstrable experience in cell culture of lymphocytes, flow cytometry and in establishing lymphocyte functional assays. In addition, the successful applicant will be expected to be actively involved in supervising and training undergraduate, MSc and PhD students, as required, as well as clinical fellows and graduate trainees within the department.
The post will be based at the Anthony Nolan Research Institute on Fleet road in London (Royal Free campus) and is a fixed term contract for 3 years.
For further information please see our website or contact the HR Department quoting reference numberNAT598. To apply, send your CV & cover letter to recruitment@anthonynolan.org
Tel: 0303 303 0303
Fax: 020 7284 8202
Closing date: 13th September 2013
Anthony Nolan is an Equal Opportunities Employer To concentrate our resources, only short listed candidates will be contacted.
为防止简历投递丢失请抄送一份至：boshijob@126.com（邮件标题格式：应聘职位名称+姓名+学历+专业+中国博士人才网）
中国-博士人才网发布
声明提示：凡本网注明“来源：XXX”的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。
